IGC
Igc Pharma
$0.26
−$0.00 (−0.38%)Jul 27, 2026
Key metrics
The numbers that frame IGC today
- Market cap
- $26.32M
- P/E (TTM)
- -4.0
- EV / FCF
- -5.0
- Gross margin
- 29.7%
- EV / Sales
- 22.6
- ROIC
- -294.1%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $0.24
- 52wk High
- $0.50
Growth
Revenue and earnings trend for IGC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IGC
Is Igc Pharma a good buy?
No. Igc Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Igc Pharma is selling at a very high price.
What is the market capitalization of IGC?
Igc Pharma's market capitalization is $26.32M.
What is the P/E ratio for IGC stock?
Igc Pharma's current P/E ratio is -4.
What is the 52-week high for IGC stock?
The 52-week high for Igc Pharma is $0.50. The current close of $0.26 is 47.2% below that high.
What is the 52-week low for IGC stock?
The 52-week low for Igc Pharma is $0.24. The current close of $0.26 is 9.6% above that low.
Does IGC stock pay dividends?
Igc Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IGC?
Igc Pharma's Debt / Equity ratio is 0.15.